Corneal lesion as the initial manifestation of tyrosinemia type II
- PMID: 16863017
- DOI: 10.1016/S1726-4901(09)70259-X
Corneal lesion as the initial manifestation of tyrosinemia type II
Abstract
Tyrosinemia type II (Richner-Hanhart syndrome) is a rare autosomal recessive disease with deficiency of tyrosine aminotransferase and subsequently increasing level of serum tyrosine. We report the case of a 2-year-old girl who was referred due to bilateral corneal lesions. Slit-lamp examination showed small granular white deposits arranged in a dendritic pattern in the superficial central cornea of both eyes. Physical examination revealed painful, non-pruritic, hyperkeratotic plaques on the soles, palms and fingertips. Mental evaluation demonstrated developmental delay for her age. Blood examination revealed serum tyrosine level to be 1868 microM (normal range, 30-110 microM), which decreased to 838 microM with 2-month diet on tyrosine and phenylalanine restriction. The corneal and skin lesions resolved completely. However, the corneal deposits recurred a month later as her mother failed to strictly control the diet because the little girl was losing weight and activity. With specific formula and adjusted diet regimen, the corneal lesions decreased again. Corneal pseudodendritic deposits may be the initial manifestation in patients with tyrosinemia type II. Early diagnosis and intervention with diet control are crucial for preventing permanent visual and developmental deficits. Corneal deposits can be one of the parameters in monitoring the efficacy of diet control.
Similar articles
-
Richner-Hanhart syndrome (tyrosinemia type II): a case report of delayed diagnosis with pseudodendritic corneal lesion.Turk J Pediatr. 2011 Nov-Dec;53(6):692-4. Turk J Pediatr. 2011. PMID: 22389994
-
In vivo confocal microscopic features of corneal pseudodendritic lesions in tyrosinemia type II.Cornea. 2014 Oct;33(10):1106-8. doi: 10.1097/ICO.0000000000000226. Cornea. 2014. PMID: 25119963
-
Richner-Hanhart syndrome (tyrosinemia II): early diagnosis of an incomplete presentation with unusual findings.Pediatr Dermatol. 2006 May-Jun;23(3):259-61. doi: 10.1111/j.1525-1470.2006.00230.x. Pediatr Dermatol. 2006. PMID: 16780475
-
Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review.Ophthalmic Genet. 1995 Mar;16(1):21-6. doi: 10.3109/13816819509057850. Ophthalmic Genet. 1995. PMID: 7648039 Review.
-
The genetic tyrosinemias.Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):121-6. doi: 10.1002/ajmg.c.30092. Am J Med Genet C Semin Med Genet. 2006. PMID: 16602095 Review.
Cited by
-
Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.Genet Med. 2017 Dec;19(12). doi: 10.1038/gim.2017.101. Epub 2017 Aug 3. Genet Med. 2017. PMID: 28771246 Free PMC article. Review.
-
Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan.J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S295-305. doi: 10.1007/s10545-010-9129-z. Epub 2010 Jun 22. J Inherit Metab Dis. 2010. PMID: 20567911
-
An Infant with Bilateral Keratitis: From Infectious to Genetic Diagnosis.Am J Case Rep. 2022 Nov 30;23:e937967. doi: 10.12659/AJCR.937967. Am J Case Rep. 2022. PMID: 36447403 Free PMC article.
-
A child with dendritiform eye lesions and developmental delay.Am J Ophthalmol Case Rep. 2022 Sep 6;28:101701. doi: 10.1016/j.ajoc.2022.101701. eCollection 2022 Dec. Am J Ophthalmol Case Rep. 2022. PMID: 36118278 Free PMC article.
-
Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation.Genes (Basel). 2020 Dec 22;12(1):3. doi: 10.3390/genes12010003. Genes (Basel). 2020. PMID: 33375092 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
